Prefilled Syringes Market Size, Share and Trends 2026 to 2035
Prefilled Syringes Market (By Type: Conventional Prefilled Syringes, Disposable Prefilled Syringes, Reusable Prefilled Syringes, Safety Prefilled Syringes; By Material: Glass, Plastic; By Design: Single-Chamber, Dual- Chamber, Customized; By Product: Complete Syringe Set, Components and Accessories; By Application: Diabetes, Rheumatoid Arthritis, Anaphylaxis, Cancer, Thrombosis, Ophthalmology, Others; By Closing System: Staked Needle System, Luer Cone System, Luer Lock Form SystemBy End User, Pharmaceutical and Biotechnology Companies, Contract Research and Manufacturing Organizations, Others) - Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2026 to 2035
Get a Sample
Table Of Content
What is Prefilled Syringes Market Size?
The prefilled syringes market size accounted for USD 21.59 billion in 2025, and is anticipated to hit around USD 24.13 billion by 2026, and is expected to reach around USD 64.69 billion by 2035, expanding at a CAGR of 11.60% from 2026 to 2035
Market Highlights
- Europe led the global market with the highest market share of 40% in 2025.
- By Type, the safety prefilled syringes segment captured the biggest revenue share in 2025.
- By Material, the glass prefilled syringes segment is estimated to hold the highest market share in 2025.
- By Design, the single-chamber prefilled syringes segment has held the largest market share in 2025.
How has AI benefited the Prefilled Syringes Industry?
Artificial intelligence has remarkably benefited the prefilled syringes industry by improving manufacturing precision, enhancing quality control via advanced inspection, and driving the development of "smart" drug delivery systems. AI allows predictive maintenance, anticipating equipment failures to decrease downtime. It also optimizes the production line by accepting acceptable variations in materials, thus minimizing false rejections.
Prefilled Syringes Market Growth Factors
A pre-filled syringe is also recognized as a package which is comprised of single-dose of medicine in which an attached needle also provided by the manufacturer. Previously, metal or glass syringes were very common in the industry of industry, but slowly & steadily consumer shift have been observed more towards disposable or plastic syringes in order to secure the needle and make it use and throw so that it cannot be re-utilized. In addition, this has revitalized the demand towards safe and convenient pre-filled syringes in the pharmaceutical market over conventional glass vials for storing drugs.
The impact of the driving factors is anticipated to surpass the effect of restraints. Also, the technological advancements leading to advanced adoption rate and untapped markets in the developing countries are anticipated to give new avenues for the growth of market in the near future. Likewise, growing use of technological advancements and prefilled syringes in auto-injectors are the crucial factors propelling the market. Furthermore, prefilled syringes are fleetly swapping traditional combinations of syringe-vial owing to advantages provided by them, similar as convenience for healthcare practitioners and increased patient safety in cure medication and delivery.
These syringes enable easy operation of chronic diseases, similar as rheumatoid arthritis, and diabetes which is anticipated to boost the use of auto-injectors and pen injectors during the forecast period. Therefore, the growing frequency of chronic disease like diabetes and other diseases is likely to fuel the market demand over the upcoming time period. In addition, the launch of advanced equipment with Wi-Fi and Bluetooth connectivity easing effective operation of patient health records is also anticipated to boost the product demand.
In addition, the usage of pre-filled syringe has skyrocketed owing to the numerous difficulties in the traditional process. There are various advantages pre-filled syringes have in place of traditional packaging in vials which comprise of ease in use. As prefilled syringes efficiently mitigate the processes which is further required before using any drug in a vial. Moreover, it further helps in removing errors while providing doses to the patient's as prefilled syringes are importantly comprise of the exact dose required for the patient. In addition, numerous producers of pharmaceuticals overfill their vials by up to 18%, however, this overfilled of vials is likely to cause many errors while giving a dose to the patient which can easily be mitigated with the help of the pre-filled syringes. Also, there exists excessive syringes development and various new products have been launched and are being kept in syringes now for the microbial safety. Pre-filled syringes are used in the packaging of injectable and diluents drugs. Some of the majorly listed drugs packaged in pre-filled syringes includes vaccines , blood stimulants, ervthroproteins, therapeutic proteins , and rheumatoid arthritis. Thus, comfort in utilization and better safety of the drug is the major factor which is leading to rise in demand for prefilled syringes in the market.
The demand for prefilled syringes has risen due to the COVID-19 pandemic. The surge in number of COVID-19 patients is paving new ways for the growth of the global prefilled syringes market during 2020. Another factor boosting the growth of the global prefilled syringes market is growing incidences of rheumatoid arthritis and diabetes all over the world. In addition, the growing concerns about the safety of injectables are propelling the prefilled syringes market. The growing technological developments in the prefilled syringes market are also driving the demand for prefilled syringes. The prefilled syringes are widely adopted in the developed and developing regions such as North America and Europe. Moreover, the surge in demand for biosimilars is also contributing to the growth of the prefilled syringes market.
Market Outlook
- Market Growth Overview: The prefilled syringes market is expected to grow significantly between 2026 and 2035, driven by the rising burden of chronic diseases, the shift towards self-administration, and the expansion of biologics and biosimilars.
- Sustainability Trends:Sustainability trends involve a shift towards eco-friendly materials, packaging optimization and waste reduction, and take-back and recycling programs.
- Major Investors: Major investors in the market include Becton, Dickinson and Company (BD), Gerresheimer AG, SCHOTT AG, West Pharmaceutical Services, Inc., Stevanato Group, and Novartis AG.
- Startup Economy: The startup economy is focused on novel materials and manufacturing, smart syringes and connectivity, and patient-centric delivery and usability.
Market Scope
| Report Coverage | Details |
| Market Size in 2025 | USD 21.59 Billion |
| Market Size in 2026 | USD 24.13 Billion |
| Market Size by 2035 | USD 64.69 Billion |
| Growth Rate from 2026 to 2035 | CAGR of 11.60% |
| Largest Market | Europe |
| Fastest Growing Market | North America |
| Base Year | 2025 |
| Forecast Period | 2026 to 2035 |
| Segments Covered | Type, Material, Design, Product, Closing System, Application, End User and Region |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Segment Insights
Type Insights
On the basis of type, safety prefilled syringes segment is likely to foresee the loftiest growth during the forthcoming time period majorly owing to the growing senior population worldwide and biological therapies availabilities for patients with suffering from chronic diseases and low- threat medical procedures outsourcing for chronic patients ease some of the pressure on hospitals.
Why did the Safety Prefilled Syringes Segment Dominate the Prefilled Syringes Market?
The safety prefilled syringes segment led the market in 2025. This is due to the critical demand to reduce needle-stick injuries and even prevent the transmission of blood-borne diseases such as HIV and Hepatitis. Governments in many regions have implemented laws demanding the use of safety-engineered devices to protect against injuries. These syringes improve convenience, provide accurate dosing, and decrease the need for and risks linked with manual drug preparation.
The conventional prefilled syringes segment is expected to grow at the fastest CAGR throughout the forecast period. This is due to its high cost-effectiveness, widespread acceptance in hospitals and clinics, and proven reliability. These syringes provide superior convenience by eliminating medication preparation, enhancing dosing accuracy, reducing contamination risks, and improving patient compliance, mainly for chronic condition treatments. They are ready-to-use, which decreases the time required for preparation, reduces medication errors, and even lowers the risk of needle stick injuries.
Material Insights
The glass prefilled syringes segment reckoned for the largest share of the prefilled syringes in 2025. The large share of this segment is attributed to the significant benefits offered, similar as forestallment of oxygen and water vapor from interacting with medicine composites , comity with different stuffing machines, and flawless integration into pharmaceutical companies PFS operations.
Why did the Glass Segment Dominate the Prefilled Syringes Market?
The glass segment dominated the market in 2025. The market is primarily because of its superior inertness, which guarantees drug stability and prevents interactions with sensitive biologics, along with high-viscosity drugs. Glass is highly inert, meaning it has low reactivity with medications, which thus prevents leaching and contamination. Glass syringes have a long history of compliance, thus making them the standard option for regulatory approval.
The plastic segment is expected to grow at a significant CAGR in the upcoming period, because of its lightweight, break-resistant, and cost-effective nature. It is ideal for high-volume vaccine production along with self-administration. Plastic enables easier integration with safety mechanisms, like needle shields and retractable needles.
Design Insights
The single- chamber prefilled syringes segment reckoned for the largest share of the prefilled syringes market. Furthermore, the market growth is majorly attributed to the significant benefits with the usage of prefilled syringes of single-chamber over vials, similar as optimized API use with lower overfill, lower medicine waste in clinical trials , reduced material requirements, and simple storage& disposal. Also, upsurge in self-administered parenteral medicines adoption owing to the adding frequency of various chronic diseases and advantages offered by them.
Why did the Single-Chamber Segment Dominate the Prefilled Syringes Market?
The single-chamber segment dominated the market in 2025. The market is primarily because of its simplicity, cost-effectiveness, and widespread usage for chronic diseases, vaccines, and biologics. Single-chamber designs are generally cheaper to produce in large volumes compared to complex dual-chamber systems. These syringes decrease medication preparation time, reduce contamination risks, and enable accurate, quick administration, making them ideal for emergency care and even high-volume vaccinations.
The dual-chamber segment is expected to grow at a significant CAGR in the upcoming period, because of the need for improved stability of biologics, lyophilized drugs, and vaccines, which demand mixing immediately before administration. They provide improved patient safety, reduced contamination risk, along with better convenience for self-administration of chronic diseases, for example, rheumatoid arthritis, hemophilia, compared to traditional vials.
Regional Insights
Europe Prefilled Syringes Market Size and Growth 2026 to 2035
The Europe prefilled syringes market size is estimated at USD 8.64 billion in 2025 and is predicted to be worth around USD 25.87 billion by 2035, at a CAGR of 11.59% from 2026 to 2035
Europe: Germany Prefilled Syringes Market Trends
Germany's market growth is driven by the aging population and high prevalence of chronic diseases. The push for self-administration of medicines and a strong regulatory environment favouring safe, user-friendly solutions. Technological innovations, such as smart and safety-featured syringes, are becoming commonplace, with glass counting to be the dominant material choice for high-value biologic drugs.
Europe is one of the major profit-generating regions in the prefilled syringes market. Rising frequency of chronic conditions, technological advancements, growth of the biologics and biosimilars market, geographical expansion by crucial manufacturers, growing population, and high adoption of tone-injection bias are driving the demand for tone-injectable prefilled syringes are the major factors driving the growth of the prefilled syringes market in Europe.
Due to expanding access to healthcare, increased uptake of advanced drug delivery systems, and increased awareness of patient safety, Asia Pacific is quickly becoming a growth hub for the prefilled syringe market. Furthermore, with Asia Pacific being one of the largest population bases in the world, bettering regulatory frameworks, local pharmaceutical manufacturing, and growing investments from global players, this puts the growth of the Asia Pacific region even more in focus as a key component of this market expansion.
How Did North America Dominate the Prefilled Syringes Market?
North America's market growth is driven by the high prevalence of chronic diseases, such as diabetes and autoimmune disorders, which necessitate frequent injections. The region benefits from a highly advanced healthcare infrastructure and substantial expenditure that accelerates the adoption of new medical technologies. Stringent U.S. FDA safety regulations heavily promote the use of pre-measured, safety-engineered syringes to minimize medication errors and needlestick injuries.
U.S. Prefilled Syringes Market Trends
The U.S. market is a growing sector driven by the high prevalence of chronic diseases and a strong regulatory emphasis on patient safety. A significant trend toward patient self-administration and home healthcare is fueling the demand for convenient, ready-to-use syringes.
Advancements of Latin America to Stimulate the Prefilled Syringes Sector
Latin America's advancement in the prefilled syringes accelerated when the sector transformed its traditional ground into patient-supportive self-service systems, particularly for rheumatoid arthritis and diabetes. Regional partnerships to fuel tech integration and manufacturing extension are a major advancement for prefilled syringes. Brazil's heavy investment is a valuable contribution to the region's advancement and growth.
Whereas, Colombia and Argentina are new facilities that strongly aims on pharmaceutical outsourcing and infrastructure establishment. With the power of millions of profits, Latin America has a sufficient amount of financial strength to further boost its advanced performance in prefilled syringes.
Brazil Prefilled Syringes Market Trends
Brazil's major trends lie in the biopharmaceuticals expansion rate, as biosimilars and new promising biologic medications are one of the fundamental drugs qualifying on the basis of precision dosing. The dosing is served by prefilled syringes to confirm safety and efficacy. The home healthcare trend promotes self-administration solutions.
The demand for convenience for indoor patients is rising with the geriatric or busy population, due to which the ready-to-use delivery method is accelerating. Alongside, intelligent packaging is gaining necessary popularity to detect expiry dates and track the usage appropriately.
Asia-Pacific Initiatives in the Prefilled Syringes Industry
Asia-Pacific government initiatives are a major contributor to the prefilled syringes market globally, as they also play a role in raising awareness and addressing new regulatory fluctuations, supporting or transitioning the sector overall. India and China deliver export subsidies, low-interest loans, and tax rebates that empower local manufacturers of the excessively produced medical devices, involving auto-disable and prefilled syringes.
The government-sponsored vaccination campaigns in the massive population region promote dosing accuracy and quick access (delivery). The Central Drugs Standard Control Organisation (CDSCO) guidelines, mainly for drug-device merger elevates approval of products in the biologics setting and confirm safety.
China's Prefilled Syringes Market Trends
China's trend revolves around the crucial biologics demand for smart drug delivery systems, mainly for anticoagulants, monoclonal antibodies, and insulin, due to which the demand for glass barrels instantly rises. The region is leading with the increased regulatory approvals and its key focus on local production.
Following this, the innovative and effective products get equal position as the market rises. The rising prevalence of chronic disease has stimulated and provoked the growth of the home care system regarding prefilled syringes, featuring convenience and comfort for the patient population. Local pharmaceutical companies plays important role in the growth of China's trend growth.
Rising Demand for Prefilled Syringes in MEA
MEA shows a rapid growth during the forecast period. It is driven by the high prevalence of chronic diseases such as diabetes and cancer, demanding consistent self-administration. The rising use of advanced, sensitive biologic therapies, which require precise dosage and, in many cases, self-injection, is boosting the acceptance of prefilled syringes.
Increased government spending on healthcare, mainly in the UAE and Saudi Arabia, has led to enhanced healthcare access and a drive toward adopting modern medical devices.
Value Chain Analysis of the Prefilled Syringes Market
- Raw Material & Component Manufacturing
This initial stage focuses on the production of the syringe barrel (typically glass or polymer), the plunger stopper, needle shield, and other critical components.
Key Players: Gerresheimer AG, SCHOTT AG, and West Pharmaceutical Services, Inc. - Prefilled Syringe Filling and Finishing (Drug Manufacturing)
This stage involves the aseptic filling of the syringe with the drug product, followed by the insertion of the plunger stopper and needle shield.
Key Players: Baxter International Inc. and Pfizer Inc., Vetter Pharma Fertigung GmbH, WuXi Biologics, and Ajinomoto Bio-Pharma Services. - Distribution and Logistics
After filling, the finished prefilled syringes are packaged, labeled, and distributed through established pharmaceutical supply chains to healthcare providers, pharmacies, and patients.
Key Players: Cardinal Health, Inc., BD (Becton, Dickinson and Company), and Fresenius Kabi AG - End-User Administration
This final stage encompasses the use of the prefilled syringe by healthcare professionals in hospitals and clinics or for self-administration by patients at home. Key Players: hospitals, ambulatory surgery centers, and individual patients.
Top Companies in the Prefilled Syringes Market & Their Offerings
- SCHOTT AG : SCHOTT AG is a global leader in specialty glass and advanced materials, contributing significantly by manufacturing high-quality glass barrels and components for prefilled syringes.
- West Pharmaceutical Services, Inc .: West is a crucial component manufacturer, specializing in the stoppers, plungers, and sealing solutions that make up the container closure system for prefilled syringes.
- Baxter International Inc.: Baxter operates as both a drug manufacturer and a major user of prefilled syringe technology, contributing by utilizing these systems for a range of their own medications and providing outsourced filling services to other pharma companies.
- Weigao Group: As a major Chinese medical device manufacturer, Weigao contributes to the global and Asia-Pacific markets by producing a wide array of medical consumables, including disposable prefilled syringes and related delivery systems.
- Vetter Pharma International GmbH: Vetter is a leading contract development and manufacturing organization (CDMO) that specializes in the high-quality aseptic filling and finishing of prefilled syringes for the global biotech and pharmaceutical industries.
- Nipro Corporation: Nipro contributes through the manufacturing of glass tubing and integrated medical device components, providing essential raw materials and finished products like prefilled syringes to the global market.
- Elcam Medical: Elcam specializes in the development and manufacturing of single-use medical devices, including components and safety features for prefilled syringes.
- Oval Medical Technologies: (Acquired by Unilife) Oval focused on developing innovative, small, and patient-friendly auto-injectors and prefilled syringe systems designed for easy self-administration. Their contribution was in pushing ergonomic design and user-centric solutions to improve patient compliance with injectable therapies.
- SHL Medical AG: SHL is a world-leading designer and manufacturer of advanced drug delivery systems, particularly auto-injectors that use prefilled syringes as the primary container. They enable pharmaceutical companies to bring user-friendly, high-tech delivery solutions to market for complex biologic treatments.
- Terumo: Terumo is a global medical device company that contributes significantly to the market by manufacturing high-quality glass and polymer prefilled syringes, along with advanced safety needles.
Recent Developments
- In January 2025, SCHOTT Pharma, a provider of drug containment and delivery solutions, launched the next generation of SCHOTT TOPPAC infuse polymer syringes, a system designed to improve safety and efficiency. The next generation of SCHOTT TOPPAC infuse syringes can be filled on existing filling lines without requiring modifications or additional investment. (Source: https://www.contractpharma.com )
- In May 2025, Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as “Zydus”) received final approval from the United States Food and Drug Administration (USFDA) for Glatiramer Acetate Injection, 20 mg/mL and 40 mg/mL, single-dose prefilled syringes. Zydus' generic Glatiramer Acetate Injection is an FDA-approved, AP-rated substitutable generics of Copaxone 20 mg/ml, 40 mg/ml and indicated for the treatment of relapsing forms of Multiple Sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. (Source: https://www.businesswire.com )
- In April 2025, Argenx announced FDA Approval of VYVGART Hytrulo Prefilled Syringe for self-injection in generalized Myasthenia Gravis and chronic inflammatory demyelinating polyneuropathy. VYVGART, the first-in-class FcRn blocker, now offers three administration options, including self-injection with a prefilled syringe. (Source: https://www.globenewswire.com )
- In November 2024, Affinity Whole Health, a pioneer in personalized healthcare solutions with a focus on in-home weight loss and hormone therapies, announced the introduction of its new compounded GLP-1 pre-filled syringes, a unique and patient-centric offering in the weight loss and metabolic health space. GLP-1 pre-filled syringes represent a significant step forward in making effective weight loss treatments more accessible and affordable. (Source: https://www.citybiz.co )
- In December 2020, Becton, Dickinson and Company (BD) to invest around USD 1.2 billion to expand its manufacturing technology and capacity of prefilled syringes. This strategy enhanced the company to create strong position in the market.
- In March 2019, SCHOTT launched syriQBioPure that is world's first lubricant free prefilled glass syringe. This innovative launch enabled the company to extend its product portfolio in this industry.
Segments Covered in the Report
By Type
- Conventional Prefilled Syringes
- Disposable Prefilled Syringes
- Reusable Prefilled Syringes
- Safety Prefilled Syringes
By Material
- Glass
- Plastic
By Design
- Single-Chamber
- Dual- Chamber
- Customized
By Product
- Complete Syringe Set
- Components and Accessories
By Application
- Diabetes
- Rheumatoid Arthritis
- Anaphylaxis
- Cancer
- Thrombosis
- Ophthalmology
- Others
By Closing System
- Staked Needle System
- Luer Cone System
- Luer Lock Form System
By End User
- Pharmaceutical and Biotechnology Companies
- Contract Research and Manufacturing Organizations
- Others
By Region
- North America
- Latin America
- Europe
- Asia-pacific
- Middle and East Africa
For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at sales@precedenceresearch.com
Frequently Asked Questions
Tags
Ask For Sample
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
sales@precedenceresearch.com
+1 804-441-9344
Schedule a Meeting